Harvard Bioscience, Inc. (HBIO)
Healthcare • Medical Instruments & Supplies
StockNasdaqCMUnited StatesUS4169062043
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Harvard Bioscience, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:54. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Nov 2026 07:00 | -0.17 | -0.06 | +64.7% | Beat |
| 11 Aug 2026 08:00 | -0.21 | — | — | — |
| 12 May 2026 07:00 | -0.95 | -0.77 | +19.0% | Beat |
| 12 Mar 2026 07:00 | 0.35 | — | -100.0% | — |
| 06 Nov 2025 07:00 | 0.05 | — | -100.0% | — |
| 11 Aug 2025 07:00 | -0.25 | -0.10 | +60.0% | Beat |
| 12 May 2025 07:00 | -0.40 | -0.10 | +75.0% | Beat |
| 12 Mar 2025 07:00 | 0.50 | 0.60 | +20.0% | Beat |
| 07 Nov 2024 07:00 | 0.15 | -0.20 | -233.3% | Miss |
| 08 Aug 2024 08:00 | 0.50 | — | -100.0% | — |
| 07 May 2024 07:00 | 0.25 | 0.20 | -20.0% | Miss |
| 07 Mar 2024 07:00 | 0.50 | 0.40 | -20.0% | Miss |
| 07 Nov 2023 07:00 | 0.40 | 0.10 | -75.0% | Miss |
| 08 Aug 2023 09:00 | 0.55 | 0.40 | -27.3% | Miss |
| 25 Apr 2023 08:00 | 0.45 | 0.60 | +33.3% | Beat |
| 09 Mar 2023 07:00 | 0.05 | 0.40 | +700.0% | Beat |
| 08 Nov 2022 16:00 | 0.55 | -0.10 | -118.2% | Miss |
| 03 Aug 2022 22:00 | 0.55 | 0.50 | -9.1% | Miss |
| 04 May 2022 07:00 | 0.55 | 0.40 | -27.3% | Miss |
| 08 Mar 2022 07:00 | 1.10 | 0.80 | -27.3% | Miss |
| 03 Nov 2021 07:00 | 0.60 | 0.60 | 0.0% | In line |
| 05 Aug 2021 07:00 | 0.65 | 0.60 | -7.7% | Miss |
| 06 May 2021 07:00 | 0.25 | 0.50 | +100.0% | Beat |
| 10 Mar 2021 07:00 | 0.65 | 0.80 | +23.1% | Beat |
| 05 Nov 2020 07:00 | 0.20 | 0.40 | +100.0% | Beat |
| 05 Aug 2020 07:00 | -0.10 | 0.50 | +600.0% | Beat |
| 05 May 2020 07:00 | 0.30 | -0.10 | -133.3% | Miss |
| 26 Feb 2020 07:00 | 0.80 | 0.80 | 0.0% | In line |
| 05 Nov 2019 16:00 | 0.50 | 0.40 | -20.0% | Miss |
| 25 Jul 2019 16:00 | 0.40 | 0.40 | 0.0% | In line |
| 02 May 2019 16:00 | 0.35 | 0.20 | -42.9% | Miss |
| 28 Feb 2019 15:00 | 0.70 | 0.70 | 0.0% | In line |
| 25 Oct 2018 16:00 | 0.40 | 0.40 | 0.0% | In line |
| 26 Jul 2018 16:00 | 0.53 | 0.70 | +31.3% | Beat |
| 02 May 2018 16:00 | 0.27 | 0.30 | +12.5% | Beat |
| 01 Mar 2018 16:00 | 0.53 | 0.50 | -6.3% | Miss |
| 26 Oct 2017 16:00 | 0.33 | 0.30 | -10.0% | Miss |
| 27 Jul 2017 16:00 | 0.30 | 0.30 | 0.0% | In line |
| 27 Apr 2017 16:00 | 0.13 | 0.20 | +50.0% | Beat |
| 09 Mar 2017 16:00 | 0.43 | 0.40 | -7.7% | Miss |
| 27 Oct 2016 16:00 | 0.30 | 0.30 | 0.0% | In line |
| 28 Jul 2016 06:00 | 0.30 | 0.30 | 0.0% | In line |
| 12 May 2016 06:00 | 0.30 | 0.50 | +66.7% | Beat |
| 29 Apr 2016 16:00 | 0.40 | 0.30 | -25.0% | Miss |
| 29 Oct 2015 06:00 | 0.50 | 0.30 | -40.0% | Miss |
| 30 Jul 2015 06:00 | 0.40 | 0.50 | +25.0% | Beat |
| 30 Apr 2015 07:00 | 0.60 | 0.20 | -66.7% | Miss |
| 26 Feb 2015 07:00 | 0.85 | 1.00 | +18.3% | Beat |
| 30 Oct 2014 07:00 | 0.63 | 0.60 | -4.0% | Miss |
| 31 Jul 2014 07:00 | 0.35 | 0.60 | +71.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 86.6M | -8.1% | -56.7M | -65.5% | -12.80 | -357.1% | 4.9M |
| 2024 | 94.1M | -16.1% | -12.4M | -13.2% | -2.80 | -250.0% | -1.8M |
| 2023 | 112.3M | -1.0% | -3.4M | -3.0% | -0.80 | +65.2% | 11.7M |
| 2022 | 113.3M | — | -9.5M | -8.4% | -2.30 | — | -438K |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 9.00 | 10.20 | 8.11 | 9.46 | +6.27% | 396,957 | |
| Oct 2026 | 7.90 | 9.00 | 7.85 | 8.90 | +12.37% | 387,300 | |
| Sep 2026 | 8.13 | 8.40 | 7.85 | 7.92 | -2.34% | 377,000 | |
| Aug 2026 | 6.02 | 8.12 | 6.01 | 8.11 | +32.95% | 469,600 | |
| Jul 2026 | 6.15 | 6.72 | 5.90 | 6.10 | -0.81% | 270,200 | |
| Jun 2026 | 5.76 | 6.69 | 5.76 | 6.15 | +4.59% | 462,000 | |
| May 2026 | 6.38 | 7.50 | 4.87 | 5.88 | -7.84% | 658,700 | |
| Apr 2026 | 4.86 | 7.00 | 4.27 | 6.38 | +31.01% | 1,449,900 | |
| Mar 2026 | 5.80 | 6.20 | 4.00 | 4.87 | -20.16% | 1,218,430 | |
| Feb 2026 | 5.00 | 6.50 | 4.70 | 6.10 | +22.00% | 1,025,430 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- StoneX Downgrades Harvard Bioscience to Hold (opens in a new tab) Benzinga · 11 Nov 2026 09:30
- Harvard Bioscience Inc (HBIO) Q3 2026 Earnings Call Highlights: Revenue Growth Accelerates as ... (opens in a new tab) GuruFocus.com · 11 Nov 2026 09:03
- Harvard Bioscience, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 10 Nov 2026 17:57
- Harvard Bioscience (HBIO) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 17:28
- Harvard Bioscience: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 10 Nov 2026 12:19
- Harvard Bioscience Announces Third Quarter 2026 Financial Results (opens in a new tab) 10 Nov 2026 12:00
- Harvard Bioscience, Inc. (HBIO) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 11:01
- Harvard Bioscience Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 10 Nov 2026 09:46
- Harvard Bioscience Raises FY2026 Sales Guidance from $88.281M-$90.012M to $89.147M-$90.877M vs $89.794M Est (opens in a new tab) Benzinga · 10 Nov 2026 08:04
- Harvard Bioscience Sees Q4 Sales $23.700M-$25.500M vs $24.500M Est (opens in a new tab) Benzinga · 10 Nov 2026 08:04
- Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum (opens in a new tab) 04 Nov 2026 12:30
- Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 18 Aug 2026 14:42
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 9.22 USD
- Market cap
- 42.1M
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow HBIO and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.